Tato stránka byla automaticky přeložena a přesnost překladu není zaručena. Podívejte se prosím na anglická verze pro zdrojový text.

Kombinovaná chemoterapie, bevacizumab a/nebo atezolizumab v léčbě pacientů s nedostatečnou opravou nesouladu DNA s metastatickým kolorektálním karcinomem, studie COMMIT

11. listopadu 2026 aktualizováno: National Cancer Institute (NCI)

Metastatická studie dMMR/MSI-H imunoterapie (COMMIT) kolorektálního karcinomu: Randomizovaná studie fáze III kombinace mFOLFOX6/Bevacizumab/Atezolizumab versus Atezolizumab v první linii léčby pacientů s deficitem DNA Mismatch/MidMid Metastatický kolorektální karcinom s vysokou nestabilitou (MSI-H).

This phase III trial studies how well combination chemotherapy, bevacizumab, and/or atezolizumab work in treating patients with deficient deoxyribonucleic acid (DNA) mismatch repair colorectal cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as fluorouracil, oxaliplatin, and leucovorin calcium, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of the tumor. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving combination chemotherapy, bevacizumab, and atezolizumab may work better in treating patients with colorectal cancer.

Přehled studie

Postavení

Aktivní, ne nábor

Podmínky

Intervence / Léčba

Detailní popis

PRIMARY OBJECTIVE:

I. To determine the efficacy, based on progression-free survival (PFS), of fluorouracil, oxaliplatin, and leucovorin calcium (modified [m]FOLFOX6)/bevacizumab plus atezolizumab (combination) as compared to single agent atezolizumab.

SECONDARY OBJECTIVES:

I. To compare the overall survival. II. To compare the objective response rates (ORR) per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1.

III. To determine the safety profiles of single agent atezolizumab and the combination of mFOLFOX6/bevacizumab/atezolizumab in patients with mismatch-repair deficient (dMMR)/microsatellite instability-high (MSI-H) metastatic colorectal cancer (mCRC).

IV. To determine the duration of response. V. To determine the duration of stable disease. VI. To determine the rate of progression-free survival (PFS) at 12 months. VII. To evaluate the disease control rate (complete response [CR] + partial response [PR] + stable disease [SD]) at 12 months.

TRANSLATIONAL OBJECTIVE:

I. To bank tissue and blood samples for other future correlative studies from patients enrolled on the study.

OUTLINE: Patients are randomized to 1 of 3 arms.

ARM I (CLOSED TO ACCRUAL 6/4/2020): Patients receive bevacizumab intravenously (IV) over 30-90 minutes on day 1, oxaliplatin IV over 2 hours on day 1 of cycles 1-10, leucovorin calcium IV over 2 hours on day 1, and fluorouracil IV over 46-48 hours on days 1 and 2. Treatment with oxaliplatin repeats every 2 weeks for up to 10 cycles in the absence of disease progression or unacceptable toxicity. Treatment of bevacizumab, leucovorin calcium, and fluorouracil repeat every 2 weeks for up to 48 cycles in the absence of disease progression or unacceptable toxicity. Patients undergo computed tomography (CT) with or without positron emission tomography (PET) or magnetic resonance imaging (MRI) throughout the trial. Patients may also undergo collection of optional blood samples throughout the trial.

ARM II: Patients receive atezolizumab IV over 30-60 minutes on day 1. Treatment repeats every 2 weeks for up to 48 cycles in the absence of disease progression or unacceptable toxicity. Patients undergo CT with or without PET or MRI throughout the trial. Patients may also undergo collection of optional blood samples throughout the trial.

ARM III: Patients receive atezolizumab IV over 30-60 minutes on day 1. Treatment repeats every 2 weeks for up to 48 cycles in the absence of disease progression or unacceptable toxicity. Patients also receive bevacizumab IV over 30-90 minutes on day 1, oxaliplatin IV over 2 hours on day 1 cycles 1-10, leucovorin calcium IV over 2 hours on day 1, and fluorouracil IV over 46-48 hours on day 1. Treatment with oxaliplatin repeats every 2 weeks for up to 10 cycles in the absence of disease progression or unacceptable toxicity. Treatment of bevacizumab, leucovorin calcium, and fluorouracil repeat every 2 weeks for up to 48 cycles in the absence of disease progression or unacceptable toxicity. Patients undergo CT with or without PET or MRI throughout the trial. Patients may also undergo collection of optional blood samples throughout the trial.

After completion of study treatment, patients are followed up every 8 weeks for 18 months, and then every 12 weeks for up to 5 years.

Typ studie

Intervenční

Zápis (Odhadovaný)

120

Fáze

  • Fáze 3

Kontakty a umístění

Tato část poskytuje kontaktní údaje pro ty, kteří studii provádějí, a informace o tom, kde se tato studie provádí.

Studijní místa

    • Arizona
      • Kingman, Arizona, Spojené státy, 86401
        • Kingman Regional Medical Center
    • Arkansas
      • Jonesboro, Arkansas, Spojené státy, 72401
        • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
    • California
      • Anaheim, California, Spojené státy, 92806
        • Kaiser Permanente-Anaheim
      • Baldwin Park, California, Spojené státy, 91706
        • Kaiser Permanente-Baldwin Park
      • Bellflower, California, Spojené státy, 90706
        • Kaiser Permanente-Bellflower
      • Berkeley, California, Spojené státy, 94704
        • Alta Bates Summit Medical Center-Herrick Campus
      • Concord, California, Spojené státy, 94520
        • John Muir Medical Center-Concord
      • Fontana, California, Spojené státy, 92335
        • Kaiser Permanente-Fontana
      • Harbor City, California, Spojené státy, 90710
        • Kaiser Permanente South Bay
      • Irvine, California, Spojené státy, 92618
        • Kaiser Permanente-Irvine
      • Los Angeles, California, Spojené státy, 90027
        • Kaiser Permanente Los Angeles Medical Center
      • Los Angeles, California, Spojené státy, 90034
        • Kaiser Permanente West Los Angeles
      • Marysville, California, Spojené státy, 95901
        • Fremont - Rideout Cancer Center
      • Modesto, California, Spojené státy, 95355
        • Memorial Medical Center
      • Ontario, California, Spojené státy, 91761
        • Kaiser Permanente-Ontario
      • Orange, California, Spojené státy, 92868
        • UC Irvine Health/Chao Family Comprehensive Cancer Center
      • Orange, California, Spojené státy, 92868
        • Saint Joseph Hospital - Orange
      • Panorama City, California, Spojené státy, 91402
        • Kaiser Permanente - Panorama City
      • Riverside, California, Spojené státy, 92505
        • Kaiser Permanente-Riverside
      • Sacramento, California, Spojené státy, 95816
        • Sutter Medical Center Sacramento
      • Sacramento, California, Spojené státy, 95817
        • University of California Davis Comprehensive Cancer Center
      • Salinas, California, Spojené státy, 93901
        • Salinas Valley Memorial
      • San Diego, California, Spojené státy, 92120
        • Kaiser Permanente-San Diego Zion
      • San Diego, California, Spojené státy, 92108
        • Kaiser Permanente-Rio San Diego
      • San Marcos, California, Spojené státy, 92078
        • Kaiser Permanente-San Marcos
      • Walnut Creek, California, Spojené státy, 94598
        • John Muir Medical Center-Walnut Creek
      • Whittier, California, Spojené státy, 90602
        • Presbyterian Intercommunity Hospital
      • Woodland Hills, California, Spojené státy, 91367
        • Kaiser Permanente-Woodland Hills
    • Colorado
      • Aurora, Colorado, Spojené státy, 80012
        • Rocky Mountain Cancer Centers-Aurora
      • Aurora, Colorado, Spojené státy, 80045
        • UCHealth University of Colorado Hospital
      • Boulder, Colorado, Spojené státy, 80303
        • Boulder Community Foothills Hospital
      • Boulder, Colorado, Spojené státy, 80304
        • Rocky Mountain Cancer Centers-Boulder
      • Colorado Springs, Colorado, Spojené státy, 80907
        • Penrose-Saint Francis Healthcare
      • Colorado Springs, Colorado, Spojené státy, 80909
        • UCHealth Memorial Hospital Central
      • Colorado Springs, Colorado, Spojené státy, 80920
        • Memorial Hospital North
      • Denver, Colorado, Spojené státy, 80218
        • Rocky Mountain Cancer Centers-Midtown
      • Denver, Colorado, Spojené státy, 80220
        • Rocky Mountain Cancer Centers-Rose
      • Denver, Colorado, Spojené státy, 80204
        • Denver Health Medical Center
      • Denver, Colorado, Spojené státy, 80206
        • National Jewish Health-Main Campus
      • Denver, Colorado, Spojené státy, 80218
        • Saint Joseph Hospital - Cancer Centers of Colorado
      • Denver, Colorado, Spojené státy, 80210
        • AdventHealth Porter
      • Englewood, Colorado, Spojené státy, 80113
        • Mountain Blue Cancer Care Center - Swedish
      • Englewood, Colorado, Spojené státy, 80113
        • Swedish Medical Center
      • Fort Collins, Colorado, Spojené státy, 80524
        • Poudre Valley Hospital
      • Fort Collins, Colorado, Spojené státy, 80528
        • Cancer Care and Hematology-Fort Collins
      • Golden, Colorado, Spojené státy, 80401
        • National Jewish Health-Western Hematology Oncology
      • Greeley, Colorado, Spojené státy, 80631
        • UCHealth Greeley Hospital
      • Greeley, Colorado, Spojené státy, 80631
        • Banner North Colorado Medical Center
      • Littleton, Colorado, Spojené státy, 80120
        • Rocky Mountain Cancer Centers-Littleton
      • Lone Tree, Colorado, Spojené státy, 80124
        • Rocky Mountain Cancer Centers-Sky Ridge
      • Loveland, Colorado, Spojené státy, 80538
        • Medical Center of the Rockies
      • Loveland, Colorado, Spojené státy, 80539
        • Banner North Colorado Medical Center - Loveland Campus
      • Thornton, Colorado, Spojené státy, 80260
        • National Jewish Health-Northern Hematology Oncology
      • Wheat Ridge, Colorado, Spojené státy, 80401
        • Intermountain Health Lutheran Hospital
    • Connecticut
      • Danbury, Connecticut, Spojené státy, 06810
        • Danbury Hospital
      • Hartford, Connecticut, Spojené státy, 06102
        • Hartford Hospital
      • Meriden, Connecticut, Spojené státy, 06451
        • Midstate Medical Center
      • New Britain, Connecticut, Spojené státy, 06050
        • The Hospital of Central Connecticut
      • Norwich, Connecticut, Spojené státy, 06360
        • William Backus Hospital
    • Delaware
      • Millville, Delaware, Spojené státy, 19967
        • Beebe South Coastal Health Campus
      • Newark, Delaware, Spojené státy, 19713
        • Helen F Graham Cancer Center
      • Newark, Delaware, Spojené státy, 19713
        • Medical Oncology Hematology Consultants PA
      • Rehoboth Beach, Delaware, Spojené státy, 19971
        • Beebe Health Campus
    • District of Columbia
      • Washington D.C., District of Columbia, Spojené státy, 20002
        • Kaiser Permanente-Capitol Hill Medical Center
    • Florida
      • Fort Lauderdale, Florida, Spojené státy, 33316
        • Broward Health Medical Center
      • Fort Myers, Florida, Spojené státy, 33905
        • Regional Cancer Center-Lee Memorial Health System
      • Gainesville, Florida, Spojené státy, 32610
        • UF Health Cancer Institute - Gainesville
      • Jacksonville, Florida, Spojené státy, 32207
        • Baptist MD Anderson Cancer Center
      • Orlando, Florida, Spojené státy, 32803
        • AdventHealth Orlando
    • Georgia
      • Albany, Georgia, Spojené státy, 31701
        • Phoebe Putney Memorial Hospital
      • Athens, Georgia, Spojené státy, 30607
        • University Cancer and Blood Center LLC
      • Augusta, Georgia, Spojené státy, 30912
        • Augusta University Medical Center
      • Augusta, Georgia, Spojené státy, 30901
        • Augusta Oncology Associates PC-D'Antignac
      • Augusta, Georgia, Spojené státy, 30909
        • Augusta Oncology Associates PC-Wheeler
      • Newnan, Georgia, Spojené státy, 30265
        • CTCA at Southeastern Regional Medical Center
    • Idaho
      • Boise, Idaho, Spojené státy, 83706
        • Saint Alphonsus Cancer Care Center-Boise
      • Boise, Idaho, Spojené státy, 83712
        • Saint Luke's Cancer Institute - Boise
      • Caldwell, Idaho, Spojené státy, 83605
        • Saint Alphonsus Cancer Care Center-Caldwell
      • Coeur d'Alene, Idaho, Spojené státy, 83814
        • Kootenai Health - Coeur d'Alene
      • Fruitland, Idaho, Spojené státy, 83619
        • Saint Luke's Cancer Institute - Fruitland
      • Meridian, Idaho, Spojené státy, 83642
        • Saint Luke's Cancer Institute - Meridian
      • Nampa, Idaho, Spojené státy, 83687
        • Saint Alphonsus Cancer Care Center-Nampa
      • Nampa, Idaho, Spojené státy, 83687
        • Saint Luke's Cancer Institute - Nampa
      • Post Falls, Idaho, Spojené státy, 83854
        • Kootenai Clinic Cancer Services - Post Falls
      • Sandpoint, Idaho, Spojené státy, 83864
        • Kootenai Clinic Cancer Services - Sandpoint
      • Twin Falls, Idaho, Spojené státy, 83301
        • Saint Luke's Cancer Institute - Twin Falls
    • Illinois
      • Bloomington, Illinois, Spojené státy, 61704
        • Illinois CancerCare-Bloomington
      • Canton, Illinois, Spojené státy, 61520
        • Illinois CancerCare-Canton
      • Carthage, Illinois, Spojené státy, 62321
        • Illinois CancerCare-Carthage
      • Centralia, Illinois, Spojené státy, 62801
        • Centralia Oncology Clinic
      • Chicago, Illinois, Spojené státy, 60612
        • University of Illinois
      • Chicago, Illinois, Spojené státy, 60612
        • Rush MD Anderson Cancer Center
      • Danville, Illinois, Spojené státy, 61832
        • Carle at The Riverfront
      • Decatur, Illinois, Spojené státy, 62526
        • Cancer Care Specialists of Illinois - Decatur
      • Dixon, Illinois, Spojené státy, 61021
        • Illinois CancerCare-Dixon
      • Effingham, Illinois, Spojené státy, 62401
        • Crossroads Cancer Center
      • Effingham, Illinois, Spojené státy, 62401
        • Carle Physician Group-Effingham
      • Eureka, Illinois, Spojené státy, 61530
        • Illinois CancerCare-Eureka
      • Evanston, Illinois, Spojené státy, 60201
        • NorthShore University HealthSystem-Evanston Hospital
      • Galesburg, Illinois, Spojené státy, 61401
        • Illinois CancerCare-Galesburg
      • Glenview, Illinois, Spojené státy, 60026
        • NorthShore University HealthSystem-Glenbrook Hospital
      • Highland Park, Illinois, Spojené státy, 60035
        • NorthShore University HealthSystem-Highland Park Hospital
      • Kewanee, Illinois, Spojené státy, 61443
        • Illinois CancerCare-Kewanee Clinic
      • Macomb, Illinois, Spojené státy, 61455
        • Illinois CancerCare-Macomb
      • Mattoon, Illinois, Spojené státy, 61938
        • Carle Physician Group-Mattoon/Charleston
      • Maywood, Illinois, Spojené státy, 60153
        • Loyola University Medical Center
      • Mount Vernon, Illinois, Spojené státy, 62864
        • SSM Health Good Samaritan
      • O'Fallon, Illinois, Spojené státy, 62269
        • Cancer Care Center of O'Fallon
      • Ottawa, Illinois, Spojené státy, 61350
        • Illinois CancerCare-Ottawa Clinic
      • Pekin, Illinois, Spojené státy, 61554
        • Illinois CancerCare-Pekin
      • Peoria, Illinois, Spojené státy, 61615
        • Illinois CancerCare-Peoria
      • Peru, Illinois, Spojené státy, 61354
        • Illinois CancerCare-Peru
      • Princeton, Illinois, Spojené státy, 61356
        • Illinois CancerCare-Princeton
      • Springfield, Illinois, Spojené státy, 62702
        • Southern Illinois University School of Medicine
      • Springfield, Illinois, Spojené státy, 62702
        • Springfield Clinic
      • Urbana, Illinois, Spojené státy, 61801
        • Carle Cancer Center
      • Washington, Illinois, Spojené státy, 61571
        • Illinois CancerCare - Washington
    • Indiana
      • Indianapolis, Indiana, Spojené státy, 46237
        • Franciscan Health Indianapolis
      • Indianapolis, Indiana, Spojené státy, 46202
        • Indiana University/Melvin and Bren Simon Cancer Center
      • Indianapolis, Indiana, Spojené státy, 46219
        • Community Cancer Center East
      • Indianapolis, Indiana, Spojené státy, 46227
        • Community Cancer Center South
      • Indianapolis, Indiana, Spojené státy, 46256
        • Community Cancer Center North
      • Kokomo, Indiana, Spojené státy, 46904
        • Community Howard Regional Health
      • Lafayette, Indiana, Spojené státy, 47905
        • Franciscan Saint Elizabeth Health - Lafayette East
      • Michigan City, Indiana, Spojené státy, 46360
        • Woodland Cancer Care Center
      • Mooresville, Indiana, Spojené státy, 46158
        • Franciscan Health Mooresville
      • Terre Haute, Indiana, Spojené státy, 47804
        • Union Hospital
    • Iowa
      • Ames, Iowa, Spojené státy, 50010
        • Mary Greeley Medical Center
      • Ames, Iowa, Spojené státy, 50010
        • McFarland Clinic - Ames
      • Bettendorf, Iowa, Spojené státy, 52722
        • University of Iowa Healthcare Cancer Services Quad Cities
      • Boone, Iowa, Spojené státy, 50036
        • McFarland Clinic - Boone
      • Cedar Rapids, Iowa, Spojené státy, 52403
        • Mercy Hospital
      • Cedar Rapids, Iowa, Spojené státy, 52403
        • Oncology Associates at Mercy Medical Center
      • Clive, Iowa, Spojené státy, 50325
        • Mercy Cancer Center-West Lakes
      • Clive, Iowa, Spojené státy, 50325
        • UI Health Care Mission Cancer and Blood - West Des Moines Clinic
      • Des Moines, Iowa, Spojené státy, 50314
        • Mercy Medical Center - Des Moines
      • Des Moines, Iowa, Spojené státy, 50314
        • Broadlawns Medical Center
      • Des Moines, Iowa, Spojené státy, 50309
        • UI Health Care Mission Cancer and Blood - Des Moines Clinic
      • Des Moines, Iowa, Spojené státy, 50314
        • UI Health Care Mission Cancer and Blood - Laurel Clinic
      • Fort Dodge, Iowa, Spojené státy, 50501
        • McFarland Clinic - Trinity Cancer Center
      • Fort Dodge, Iowa, Spojené státy, 50501
        • UI Healthcare Mission Cancer and Blood - Fort Dodge
      • Iowa City, Iowa, Spojené státy, 52242
        • University of Iowa/Holden Comprehensive Cancer Center
      • Jefferson, Iowa, Spojené státy, 50129
        • McFarland Clinic - Jefferson
      • Marshalltown, Iowa, Spojené státy, 50158
        • McFarland Clinic - Marshalltown
      • West Des Moines, Iowa, Spojené státy, 50266
        • Mercy Medical Center-West Lakes
    • Kansas
      • Hays, Kansas, Spojené státy, 67601
        • HaysMed
      • Lawrence, Kansas, Spojené státy, 66044
        • Lawrence Memorial Hospital
      • Olathe, Kansas, Spojené státy, 66061
        • The University of Kansas Cancer Center - Olathe
      • Salina, Kansas, Spojené státy, 67401
        • Salina Regional Health Center
      • Topeka, Kansas, Spojené státy, 66606
        • University of Kansas Health System Saint Francis Campus
      • Westwood, Kansas, Spojené státy, 66205
        • University of Kansas Hospital-Westwood Cancer Center
      • Wichita, Kansas, Spojené státy, 67208
        • Cancer Center of Kansas-Wichita Medical Arts Tower
      • Wichita, Kansas, Spojené státy, 67214
        • Cancer Center of Kansas - Wichita
    • Kentucky
      • Bardstown, Kentucky, Spojené státy, 40004
        • CommonSpirit Saint Joseph Hospital - Bardstown
      • Lexington, Kentucky, Spojené státy, 40536
        • University of Kentucky/Markey Cancer Center
      • Lexington, Kentucky, Spojené státy, 40503
        • Baptist Health Lexington
      • Lexington, Kentucky, Spojené státy, 40509
        • CommonSpirit Saint Joseph Medical Center - East Lexington
      • Louisville, Kentucky, Spojené státy, 40202
        • Norton Hospital Pavilion and Medical Campus
      • Louisville, Kentucky, Spojené státy, 40241
        • Norton Brownsboro Hospital and Medical Campus
      • Louisville, Kentucky, Spojené státy, 40217
        • Norton Audubon Hospital and Medical Campus
    • Louisiana
      • Kenner, Louisiana, Spojené státy, 70065
        • Ochsner Medical Center Kenner
      • New Orleans, Louisiana, Spojené státy, 70121
        • Ochsner Medical Center Jefferson
    • Maine
      • Augusta, Maine, Spojené státy, 04330
        • Harold Alfond Center for Cancer Care
      • Bangor, Maine, Spojené státy, 04401
        • Eastern Maine Medical Center
      • Belfast, Maine, Spojené státy, 04915
        • MaineHealth Waldo Hospital
      • Biddeford, Maine, Spojené státy, 04005
        • MaineHealth Maine Medical Center - Biddeford
      • Brewer, Maine, Spojené státy, 04412
        • Lafayette Family Cancer Center-EMMC
      • Rockport, Maine, Spojené státy, 04856
        • Penobscot Bay Medical Center
      • Sanford, Maine, Spojené státy, 04073
        • MaineHealth Cancer Care and IV Therapy - Sanford
      • South Portland, Maine, Spojené státy, 04106
        • MaineHealth Cancer Care and IV Therapy - South Portland
    • Maryland
      • Baltimore, Maryland, Spojené státy, 21244
        • Kaiser Permanente-Woodlawn Medical Center
      • Easton, Maryland, Spojené státy, 21601
        • University of Maryland Shore Medical Center at Easton
      • Gaithersburg, Maryland, Spojené státy, 20879
        • Kaiser Permanente-Gaithersburg Medical Center
      • Largo, Maryland, Spojené státy, 20774
        • Kaiser Permanente - Largo Medical Center
      • Lutherville, Maryland, Spojené státy, 21093
        • Kaiser Permanente Lutherville - Timonium Medical Center
    • Massachusetts
      • Boston, Massachusetts, Spojené státy, 02215
        • Dana-Farber Cancer Institute
      • Lowell, Massachusetts, Spojené státy, 01854
        • Lowell General Hospital
    • Michigan
      • Ann Arbor, Michigan, Spojené státy, 48106
        • Trinity Health Saint Joseph Mercy Hospital Ann Arbor
      • Bay City, Michigan, Spojené státy, 48706
        • McLaren Cancer Institute-Bay City
      • Bloomfield, Michigan, Spojené státy, 48302
        • McLaren Cancer Institute-Bloomfield
      • Brighton, Michigan, Spojené státy, 48114
        • Trinity Health IHA Medical Group Hematology Oncology - Brighton
      • Brighton, Michigan, Spojené státy, 48114
        • Trinity Health Medical Center - Brighton
      • Brownstown, Michigan, Spojené státy, 48183
        • Henry Ford Cancer Institute-Downriver
      • Canton, Michigan, Spojené státy, 48188
        • Trinity Health IHA Medical Group Hematology Oncology - Canton
      • Canton, Michigan, Spojené státy, 48188
        • Trinity Health Medical Center - Canton
      • Chelsea, Michigan, Spojené státy, 48118
        • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital
      • Chelsea, Michigan, Spojené státy, 48118
        • Chelsea Hospital
      • Clarkston, Michigan, Spojené státy, 48346
        • McLaren Cancer Institute-Clarkston
      • Clarkston, Michigan, Spojené státy, 48346
        • Hematology Oncology Consultants-Clarkston
      • Clarkston, Michigan, Spojené státy, 48346
        • Newland Medical Associates-Clarkston
      • Clinton Township, Michigan, Spojené státy, 48038
        • Henry Ford Macomb Hospital-Clinton Township
      • Dearborn, Michigan, Spojené státy, 48126
        • Henry Ford Medical Center-Fairlane
      • Detroit, Michigan, Spojené státy, 48202
        • Henry Ford Hospital
      • Detroit, Michigan, Spojené státy, 48201
        • Wayne State University/Karmanos Cancer Institute
      • Farmington Hills, Michigan, Spojené státy, 48334
        • Weisberg Cancer Treatment Center
      • Flint, Michigan, Spojené státy, 48532
        • McLaren Cancer Institute-Flint
      • Flint, Michigan, Spojené státy, 48532
        • Singh and Arora Hematology Oncology PC
      • Grand Rapids, Michigan, Spojené státy, 49503
        • Corewell Health Grand Rapids Hospitals - Butterworth Hospital
      • Jackson, Michigan, Spojené státy, 49201
        • Allegiance Health
      • Kalamazoo, Michigan, Spojené státy, 49007
        • West Michigan Cancer Center
      • Lansing, Michigan, Spojené státy, 48910
        • Karmanos Cancer Institute at McLaren Greater Lansing
      • Lansing, Michigan, Spojené státy, 48912
        • University of Michigan Health - Sparrow Lansing
      • Lapeer, Michigan, Spojené státy, 48446
        • McLaren Cancer Institute-Lapeer Region
      • Livonia, Michigan, Spojené státy, 48154
        • Trinity Health Saint Mary Mercy Livonia Hospital
      • Livonia, Michigan, Spojené státy, 48154
        • Hope Cancer Clinic
      • Mount Clemens, Michigan, Spojené státy, 48043
        • McLaren Cancer Institute-Macomb
      • Mount Pleasant, Michigan, Spojené státy, 48858
        • McLaren Cancer Institute-Central Michigan
      • Novi, Michigan, Spojené státy, 48377
        • Henry Ford Medical Center-Columbus
      • Petoskey, Michigan, Spojené státy, 49770
        • McLaren Cancer Institute-Northern Michigan
      • Pontiac, Michigan, Spojené státy, 48341
        • Trinity Health Saint Joseph Mercy Oakland Hospital
      • Pontiac, Michigan, Spojené státy, 48341
        • Trinity Health IHA Medical Group-Alice Gustafson Center
      • Port Huron, Michigan, Spojené státy, 48060
        • McLaren-Port Huron
      • Saginaw, Michigan, Spojené státy, 48604
        • Oncology Hematology Associates of Saginaw Valley PC
      • Saginaw, Michigan, Spojené státy, 48601
        • MyMichigan Medical Center Saginaw
      • Tawas City, Michigan, Spojené státy, 48764
        • MyMichigan Medical Center Tawas
      • Traverse City, Michigan, Spojené státy, 49684
        • Munson Medical Center
      • West Bloomfield, Michigan, Spojené státy, 48322
        • Henry Ford West Bloomfield Hospital
      • West Branch, Michigan, Spojené státy, 48661
        • Saint Mary's Oncology/Hematology Associates of West Branch
      • Ypsilanti, Michigan, Spojené státy, 48197
        • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus
    • Minnesota
      • Bemidji, Minnesota, Spojené státy, 56601
        • Sanford Joe Lueken Cancer Center
      • Burnsville, Minnesota, Spojené státy, 55337
        • Minnesota Oncology - Burnsville
      • Deer River, Minnesota, Spojené státy, 56636
        • Essentia Health - Deer River Clinic
      • Duluth, Minnesota, Spojené státy, 55805
        • Essentia Health Cancer Center
      • Hibbing, Minnesota, Spojené státy, 55746
        • Essentia Health Hibbing Clinic
      • Maplewood, Minnesota, Spojené státy, 55109
        • Saint John's Hospital - Healtheast
      • Maplewood, Minnesota, Spojené státy, 55109
        • Minnesota Oncology Hematology PA-Maplewood
      • Minneapolis, Minnesota, Spojené státy, 55415
        • Hennepin County Medical Center
      • Minneapolis, Minnesota, Spojené státy, 55454
        • Health Partners Inc
      • Saint Paul, Minnesota, Spojené státy, 55101
        • Regions Hospital
      • Saint Paul, Minnesota, Spojené státy, 55102
        • United Hospital
      • Sandstone, Minnesota, Spojené státy, 55072
        • Essentia Health Sandstone
      • Virginia, Minnesota, Spojené státy, 55792
        • Essentia Health Virginia Clinic
    • Mississippi
      • Grenada, Mississippi, Spojené státy, 38901
        • Baptist Cancer Center-Grenada
      • New Albany, Mississippi, Spojené státy, 38652
        • Baptist Memorial Hospital and Cancer Center-Union County
      • Oxford, Mississippi, Spojené státy, 38655
        • Baptist Memorial Hospital and Cancer Center-Oxford
      • Southhaven, Mississippi, Spojené státy, 38671
        • Baptist Memorial Hospital and Cancer Center-Desoto
    • Missouri
      • Ballwin, Missouri, Spojené státy, 63011
        • Mercy Oncology and Hematology - Clayton-Clarkson
      • Cape Girardeau, Missouri, Spojené státy, 63703
        • Saint Francis Medical Center
      • Columbia, Missouri, Spojené státy, 65212
        • MU Health - University Hospital/Ellis Fischel Cancer Center
      • Joplin, Missouri, Spojené státy, 64804
        • Freeman Health System
      • Joplin, Missouri, Spojené státy, 64804
        • Mercy Hospital Joplin
      • Kansas City, Missouri, Spojené státy, 64108
        • University Health Truman Medical Center
      • St Louis, Missouri, Spojené státy, 63109
        • Mercy Infusion Center - Chippewa
      • St Louis, Missouri, Spojené státy, 63141
        • Mercy Hospital Saint Louis
    • Montana
      • Anaconda, Montana, Spojené státy, 59711
        • Community Hospital of Anaconda
      • Billings, Montana, Spojené státy, 59101
        • Billings Clinic Cancer Center
      • Bozeman, Montana, Spojené státy, 59715
        • Bozeman Health Deaconess Hospital
      • Great Falls, Montana, Spojené státy, 59405
        • Great Falls Clinic
      • Great Falls, Montana, Spojené státy, 59405
        • Benefis Sletten Cancer Institute
      • Helena, Montana, Spojené státy, 59601
        • Saint Peter's Community Hospital
      • Kalispell, Montana, Spojené státy, 59901
        • Logan Health Medical Center
      • Missoula, Montana, Spojené státy, 59804
        • Community Medical Center
    • Nebraska
      • Omaha, Nebraska, Spojené státy, 68114
        • Nebraska Methodist Hospital
    • Nevada
      • Las Vegas, Nevada, Spojené státy, 89102
        • OptumCare Cancer Care at Charleston
      • Las Vegas, Nevada, Spojené státy, 89128
        • OptumCare Cancer Care at MountainView
      • Las Vegas, Nevada, Spojené státy, 89183
        • OptumCare Cancer Care at Fort Apache
      • Reno, Nevada, Spojené státy, 89502
        • Renown Regional Medical Center
    • New Hampshire
      • Lebanon, New Hampshire, Spojené státy, 03756
        • Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center
      • Manchester, New Hampshire, Spojené státy, 03104
        • Dartmouth Cancer Center - Manchester/ DCC Manchester
      • Nashua, New Hampshire, Spojené státy, 03063
        • Dartmouth Cancer Center - Nashua
    • New Jersey
      • Hamilton, New Jersey, Spojené státy, 08690
        • The Cancer Institute of New Jersey Hamilton
      • Morristown, New Jersey, Spojené státy, 07960
        • Morristown Medical Center
      • New Brunswick, New Jersey, Spojené státy, 08903
        • Rutgers Cancer Institute of New Jersey
      • Paramus, New Jersey, Spojené státy, 07652
        • The Valley Hospital - Luckow Pavilion
      • Ridgewood, New Jersey, Spojené státy, 07450
        • Valley Health System Ridgewood Campus
      • Somerville, New Jersey, Spojené státy, 08876
        • Robert Wood Johnson University Hospital Somerset
      • Summit, New Jersey, Spojené státy, 07902
        • Overlook Hospital
    • New Mexico
      • Albuquerque, New Mexico, Spojené státy, 87106
        • University of New Mexico Cancer Center
      • Albuquerque, New Mexico, Spojené státy, 87110
        • Presbyterian Kaseman Hospital
      • Las Cruces, New Mexico, Spojené státy, 88011
        • Memorial Medical Center-Las Cruces
      • Rio Rancho, New Mexico, Spojené státy, 87124
        • Presbyterian Rust Medical Center/Jorgensen Cancer Center
    • New York
      • Buffalo, New York, Spojené státy, 14263
        • Roswell Park Cancer Institute
      • Elmira, New York, Spojené státy, 14905
        • Arnot Ogden Medical Center/Falck Cancer Center
      • Lake Success, New York, Spojené státy, 11042
        • Northwell Health/Center for Advanced Medicine
      • New York, New York, Spojené státy, 10016
        • Laura and Isaac Perlmutter Cancer Center at NYU Langone
      • Rochester, New York, Spojené státy, 14642
        • University of Rochester
      • White Plains, New York, Spojené státy, 10601
        • Dickstein Cancer Treatment Center
    • North Carolina
      • Chapel Hill, North Carolina, Spojené státy, 27599
        • UNC Lineberger Comprehensive Cancer Center
      • Clinton, North Carolina, Spojené státy, 28328
        • Southeastern Medical Oncology Center-Clinton
      • Goldsboro, North Carolina, Spojené státy, 27534
        • Southeastern Medical Oncology Center-Goldsboro
      • Hendersonville, North Carolina, Spojené státy, 28791
        • Margaret R Pardee Memorial Hospital
      • Jacksonville, North Carolina, Spojené státy, 28546
        • Southeastern Medical Oncology Center-Jacksonville
      • Kenansville, North Carolina, Spojené státy, 28349
        • ECU Health Oncology Kenansville
      • Kinston, North Carolina, Spojené státy, 28501
        • ECU Health Oncology Kinston
      • Pinehurst, North Carolina, Spojené státy, 28374
        • FirstHealth of the Carolinas-Moore Regional Hospital
      • Richlands, North Carolina, Spojené státy, 28574
        • ECU Health Oncology Richlands
      • Winston-Salem, North Carolina, Spojené státy, 27157
        • Wake Forest University Health Sciences
    • North Dakota
      • Bismarck, North Dakota, Spojené státy, 58501
        • Sanford Bismarck Medical Center
      • Fargo, North Dakota, Spojené státy, 58122
        • Sanford Roger Maris Cancer Center
      • Fargo, North Dakota, Spojené státy, 58122
        • Sanford Broadway Medical Center
      • Grand Forks, North Dakota, Spojené státy, 58201
        • Altru Cancer Center
    • Ohio
      • Akron, Ohio, Spojené státy, 44307
        • Cleveland Clinic Akron General
      • Belpre, Ohio, Spojené státy, 45714
        • Strecker Cancer Center-Belpre
      • Centerville, Ohio, Spojené státy, 45459
        • Miami Valley Hospital South
      • Centerville, Ohio, Spojené státy, 45459
        • Dayton Physicians LLC-Miami Valley South
      • Chillicothe, Ohio, Spojené státy, 45601
        • Adena Regional Medical Center
      • Cincinnati, Ohio, Spojené státy, 45219
        • University of Cincinnati Cancer Center-UC Medical Center
      • Cleveland, Ohio, Spojené státy, 44111
        • Cleveland Clinic Cancer Center/Fairview Hospital
      • Columbus, Ohio, Spojené státy, 43214
        • Riverside Methodist Hospital
      • Columbus, Ohio, Spojené státy, 43210
        • Ohio State University Comprehensive Cancer Center
      • Columbus, Ohio, Spojené státy, 43219
        • The Mark H Zangmeister Center
      • Columbus, Ohio, Spojené státy, 43214
        • Columbus Oncology and Hematology Associates Inc
      • Columbus, Ohio, Spojené státy, 43228
        • Doctors Hospital
      • Columbus, Ohio, Spojené státy, 43213
        • Mount Carmel East Hospital
      • Columbus, Ohio, Spojené státy, 43215
        • Grant Medical Center
      • Columbus, Ohio, Spojené státy, 43222
        • Mount Carmel Health Center West
      • Dayton, Ohio, Spojené státy, 45409
        • Miami Valley Hospital
      • Delaware, Ohio, Spojené státy, 43015
        • Delaware Health Center-Grady Cancer Center
      • Delaware, Ohio, Spojené státy, 43015
        • Grady Memorial Hospital
      • Kettering, Ohio, Spojené státy, 45409
        • Greater Dayton Cancer Center
      • Lancaster, Ohio, Spojené státy, 43130
        • Fairfield Medical Center
      • Mansfield, Ohio, Spojené státy, 44906
        • Cleveland Clinic Cancer Center Mansfield
      • Mansfield, Ohio, Spojené státy, 44903
        • OhioHealth Mansfield Hospital
      • Marietta, Ohio, Spojené státy, 45750
        • Marietta Memorial Hospital
      • Marion, Ohio, Spojené státy, 43302
        • OhioHealth Marion General Hospital
      • Mayfield Heights, Ohio, Spojené státy, 44124
        • Hillcrest Hospital Cancer Center
      • Mount Vernon, Ohio, Spojené státy, 43050
        • Knox Community Hospital
      • Newark, Ohio, Spojené státy, 43055
        • Licking Memorial Hospital
      • Portsmouth, Ohio, Spojené státy, 45662
        • Southern Ohio Medical Center
      • Sandusky, Ohio, Spojené státy, 44870
        • North Coast Cancer Care
      • Sylvania, Ohio, Spojené státy, 43560
        • ProMedica Flower Hospital
      • Warrensville Heights, Ohio, Spojené státy, 44122
        • South Pointe Hospital
      • West Chester, Ohio, Spojené státy, 45069
        • University of Cincinnati Cancer Center-West Chester
      • Westerville, Ohio, Spojené státy, 43081
        • Saint Ann's Hospital
      • Zanesville, Ohio, Spojené státy, 43701
        • Genesis Healthcare System Cancer Care Center
    • Oklahoma
      • Lawton, Oklahoma, Spojené státy, 73505
        • Cancer Centers of Southwest Oklahoma Research
      • Oklahoma City, Oklahoma, Spojené státy, 73104
        • University of Oklahoma Health Sciences Center
      • Tulsa, Oklahoma, Spojené státy, 74146
        • Oklahoma Cancer Specialists and Research Institute-Tulsa
      • Tulsa, Oklahoma, Spojené státy, 74133
        • Cancer Treatment Centers of America
    • Oregon
      • Bend, Oregon, Spojené státy, 97701
        • Saint Charles Health System
      • Clackamas, Oregon, Spojené státy, 97015
        • Clackamas Radiation Oncology Center
      • Clackamas, Oregon, Spojené státy, 97015
        • Providence Cancer Institute Clackamas Clinic
      • Newberg, Oregon, Spojené státy, 97132
        • Providence Newberg Medical Center
      • Ontario, Oregon, Spojené státy, 97914
        • Saint Alphonsus Cancer Care Center-Ontario
      • Oregon City, Oregon, Spojené státy, 97045
        • Providence Willamette Falls Medical Center
      • Portland, Oregon, Spojené státy, 97213
        • Providence Portland Medical Center
      • Portland, Oregon, Spojené státy, 97225
        • Providence Saint Vincent Medical Center
    • Pennsylvania
      • Allentown, Pennsylvania, Spojené státy, 18103
        • Lehigh Valley Hospital-Cedar Crest
      • Allentown, Pennsylvania, Spojené státy, 18104
        • Saint Luke's Cancer Center - Allentown
      • Bethlehem, Pennsylvania, Spojené státy, 18017
        • Lehigh Valley Hospital - Muhlenberg
      • Bethlehem, Pennsylvania, Spojené státy, 18015
        • Saint Luke's University Hospital-Bethlehem Campus
      • Easton, Pennsylvania, Spojené státy, 18045
        • Saint Luke's Hospital-Anderson Campus
      • Erie, Pennsylvania, Spojené státy, 16544
        • Saint Vincent Hospital
      • Harrisburg, Pennsylvania, Spojené státy, 17109
        • UPMC Pinnacle Cancer Center/Community Osteopathic Campus
      • Jefferson Hills, Pennsylvania, Spojené státy, 15025
        • Jefferson Hospital
      • Monroeville, Pennsylvania, Spojené státy, 15146
        • Forbes Hospital
      • Natrona Heights, Pennsylvania, Spojené státy, 15065
        • Allegheny Valley Hospital
      • Pittsburgh, Pennsylvania, Spojené státy, 15212
        • Allegheny General Hospital
      • Pittsburgh, Pennsylvania, Spojené státy, 15224
        • West Penn Hospital
      • Pittsburgh, Pennsylvania, Spojené státy, 15232
        • UPMC Hillman Cancer Center
      • Quakertown, Pennsylvania, Spojené státy, 18951
        • Saint Luke's Hospital-Quakertown Campus
      • West Reading, Pennsylvania, Spojené státy, 19611
        • Reading Hospital
      • Wexford, Pennsylvania, Spojené státy, 15090
        • Wexford Health and Wellness Pavilion
      • Willow Grove, Pennsylvania, Spojené státy, 19090
        • Asplundh Cancer Pavilion
    • South Carolina
      • Anderson, South Carolina, Spojené státy, 29621
        • AnMed Health Cancer Center
      • Beaufort, South Carolina, Spojené státy, 29902
        • Beaufort Memorial Hospital
      • Boiling Springs, South Carolina, Spojené státy, 29316
        • Prisma Health Cancer Institute - Spartanburg
      • Easley, South Carolina, Spojené státy, 29640
        • Prisma Health Cancer Institute - Easley
      • Greenville, South Carolina, Spojené státy, 29605
        • Prisma Health Cancer Institute - Faris
      • Greenville, South Carolina, Spojené státy, 29607
        • Saint Francis Cancer Center
      • Greenville, South Carolina, Spojené státy, 29615
        • Prisma Health Cancer Institute - Eastside
      • Greenville, South Carolina, Spojené státy, 29605
        • Prisma Health Cancer Institute - Butternut
      • Greenville, South Carolina, Spojené státy, 29601
        • Saint Francis Hospital
      • Greer, South Carolina, Spojené státy, 29650
        • Prisma Health Cancer Institute - Greer
      • Seneca, South Carolina, Spojené státy, 29672
        • Prisma Health Cancer Institute - Seneca
      • Spartanburg, South Carolina, Spojené státy, 29303
        • Spartanburg Medical Center
    • South Dakota
      • Aberdeen, South Dakota, Spojené státy, 57401
        • Avera Cancer Institute-Aberdeen
      • Sioux Falls, South Dakota, Spojené státy, 57105
        • Avera Cancer Institute
      • Sioux Falls, South Dakota, Spojené státy, 57117-5134
        • Sanford USD Medical Center - Sioux Falls
      • Sioux Falls, South Dakota, Spojené státy, 57104
        • Sanford Cancer Center Oncology Clinic
    • Tennessee
      • Bristol, Tennessee, Spojené státy, 37620
        • Bristol Regional Medical Center
      • Collierville, Tennessee, Spojené státy, 38017
        • Baptist Memorial Hospital and Cancer Center-Collierville
      • Cookeville, Tennessee, Spojené státy, 38501
        • Cookeville Regional Medical Center
      • Johnson City, Tennessee, Spojené státy, 37604
        • Wellmont Medical Associates Oncology and Hematology-Johnson City
      • Kingsport, Tennessee, Spojené státy, 37660
        • Ballad Health Cancer Care - Kingsport
      • Kingsport, Tennessee, Spojené státy, 37660
        • Wellmont Holston Valley Hospital and Medical Center
      • Memphis, Tennessee, Spojené státy, 38120
        • Baptist Memorial Hospital and Cancer Center-Memphis
    • Texas
      • Amarillo, Texas, Spojené státy, 79106
        • The Don and Sybil Harrington Cancer Center
      • Beaumont, Texas, Spojené státy, 77701
        • Baptist Hospitals of Southeast Texas Cancer Center
      • Conroe, Texas, Spojené státy, 77384
        • UT MD Anderson - The Woodlands
      • Dallas, Texas, Spojené státy, 75235
        • Parkland Memorial Hospital
      • Dallas, Texas, Spojené státy, 75390
        • UT Southwestern/Simmons Cancer Center-Dallas
      • Edinburg, Texas, Spojené státy, 78539
        • STCC at DHR Health Institute for Research and Development
      • Houston, Texas, Spojené státy, 77026-1967
        • Lyndon Baines Johnson General Hospital
      • Houston, Texas, Spojené státy, 77030
        • UT MD Anderson Cancer Center
      • Houston, Texas, Spojené státy, 77030
        • Houston Methodist Hospital
      • Houston, Texas, Spojené státy, 77079
        • UT MD Anderson - West Houston
      • League City, Texas, Spojené státy, 77573
        • UT MD Anderson - League City
      • Port Arthur, Texas, Spojené státy, 77642
        • Baptist Regional Cancer Network-Cancer Center of Southeast Texas
      • Sugar Land, Texas, Spojené státy, 77478
        • UT MD Anderson - Sugar Land
      • Temple, Texas, Spojené státy, 76508
        • Scott and White Memorial Hospital
    • Utah
      • Salt Lake City, Utah, Spojené státy, 84112
        • Huntsman Cancer Institute/University of Utah
    • Vermont
      • Saint Johnsbury, Vermont, Spojené státy, 05819
        • Dartmouth Cancer Center - North
    • Virginia
      • Bristol, Virginia, Spojené státy, 24201
        • Ballad Health Cancer Care - Bristol
      • Burke, Virginia, Spojené státy, 22015
        • Kaiser Permanente-Burke Medical Center
      • Fishersville, Virginia, Spojené státy, 22939
        • Augusta Health Center for Cancer and Blood Disorders
      • Lynchburg, Virginia, Spojené státy, 24501
        • Centra Alan B Pearson Regional Cancer Center
      • McLean, Virginia, Spojené státy, 22102
        • Kaiser Permanente Tysons Corner Medical Center
      • Norton, Virginia, Spojené státy, 24273
        • Ballad Health Cancer Care - Norton
      • Richmond, Virginia, Spojené státy, 23235
        • VCU Massey Cancer Center at Stony Point
      • Richmond, Virginia, Spojené státy, 23229
        • Virginia Cancer Institute
      • Richmond, Virginia, Spojené státy, 23298
        • VCU Massey Comprehensive Cancer Center
      • South Hill, Virginia, Spojené státy, 23970
        • VCU Community Memorial Health Center
      • Woodbridge, Virginia, Spojené státy, 22192
        • Kaiser Permanente-Caton Hill Medical Center
    • Washington
      • Edmonds, Washington, Spojené státy, 98026
        • Swedish Cancer Institute-Edmonds
      • Issaquah, Washington, Spojené státy, 98029
        • Swedish Cancer Institute-Issaquah
      • Port Townsend, Washington, Spojené státy, 98368
        • Jefferson Healthcare
      • Seattle, Washington, Spojené státy, 98122
        • Swedish Medical Center-First Hill
      • Spokane, Washington, Spojené státy, 99204
        • MultiCare Deaconess Cancer and Blood Specialty Center - Downtown
      • Spokane, Washington, Spojené státy, 99218
        • MultiCare Deaconess Cancer and Blood Specialty Center - North
    • West Virginia
      • Charleston, West Virginia, Spojené státy, 25304
        • Vandalia Health/CAMC Institute for Academic Medicine
      • Morgantown, West Virginia, Spojené státy, 26506
        • West Virginia University Healthcare
      • Parkersburg, West Virginia, Spojené státy, 26101
        • Camden Clark Medical Center
    • Wisconsin
      • Antigo, Wisconsin, Spojené státy, 54409
        • Aspirus Cancer Care-Antigo-Volm Cancer Center
      • Appleton, Wisconsin, Spojené státy, 54911
        • ThedaCare Regional Cancer Center
      • Appleton, Wisconsin, Spojené státy, 54915
        • Ascension Northeast Wisconsin-Saint Elizabeth Cancer Center-Appleton
      • Ashland, Wisconsin, Spojené státy, 54806
        • Duluth Clinic Ashland
      • Brookfield, Wisconsin, Spojené státy, 53045
        • Ascension Southeast Wisconsin Hospital-Elmbrook Campus-Brookfield
      • Eau Claire, Wisconsin, Spojené státy, 54701
        • Marshfield Medical Center-EC Cancer Center
      • Franklin, Wisconsin, Spojené státy, 53132
        • Reiman Cancer Center-Ascension Wisconsin Health Center-Rawson
      • Green Bay, Wisconsin, Spojené státy, 54301
        • Bellin Memorial Hospital
      • Janesville, Wisconsin, Spojené státy, 53548
        • Mercyhealth Hospital and Cancer Center - Janesville
      • Johnson Creek, Wisconsin, Spojené státy, 53038
        • University of Wisconsin Carbone Cancer Center - Johnson Creek
      • La Crosse, Wisconsin, Spojené státy, 54601
        • Gundersen Lutheran Medical Center
      • Madison, Wisconsin, Spojené státy, 53792
        • University of Wisconsin Carbone Cancer Center - University Hospital
      • Madison, Wisconsin, Spojené státy, 53718
        • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center
      • Marshfield, Wisconsin, Spojené státy, 54449
        • Marshfield Medical Center-Marshfield
      • Medford, Wisconsin, Spojené státy, 54451
        • Aspirus Medford Hospital
      • Minocqua, Wisconsin, Spojené státy, 54548
        • Marshfield Medical Center - Minocqua
      • Mukwonago, Wisconsin, Spojené státy, 53149
        • ProHealth D N Greenwald Center
      • New Richmond, Wisconsin, Spojené státy, 54017
        • Cancer Center of Western Wisconsin
      • Oconomowoc, Wisconsin, Spojené státy, 53066
        • ProHealth Oconomowoc Memorial Hospital
      • Oshkosh, Wisconsin, Spojené státy, 54904
        • Ascension Northeast Wisconsin-Mercy Hospital-Oshkosh
      • Racine, Wisconsin, Spojené státy, 53405
        • Ascension All Saints Hospital-Spring Street-Racine
      • Rhinelander, Wisconsin, Spojené státy, 54501
        • Aspirus Cancer Care-Rhinelander-James Beck Cancer Center
      • Rice Lake, Wisconsin, Spojené státy, 54868
        • Marshfield Medical Center-Rice Lake
      • Stevens Point, Wisconsin, Spojené státy, 54482
        • Marshfield Medical Center-River Region at Stevens Point
      • Waukesha, Wisconsin, Spojené státy, 53188
        • UW Cancer Center at ProHealth Care
      • Waukesha, Wisconsin, Spojené státy, 53188
        • ProHealth Waukesha Memorial Hospital
      • Wausau, Wisconsin, Spojené státy, 54401
        • Aspirus Cancer Care-Wausau
      • Wauwatosa, Wisconsin, Spojené státy, 53226
        • Ascension Southeast Wisconsin Hospital-Mayfair Road-Wauwatosa
      • Weston, Wisconsin, Spojené státy, 54476
        • Marshfield Medical Center - Weston
      • Wisconsin Rapids, Wisconsin, Spojené státy, 54494
        • Aspirus Cancer Care - Wisconsin Rapids
    • Wyoming
      • Cheyenne, Wyoming, Spojené státy, 82001
        • Cheyenne Regional Medical Center-West
      • Cody, Wyoming, Spojené státy, 82414
        • Billings Clinic-Cody

Kritéria účasti

Výzkumníci hledají lidi, kteří odpovídají určitému popisu, kterému se říká kritéria způsobilosti. Některé příklady těchto kritérií jsou celkový zdravotní stav osoby nebo předchozí léčba.

Kritéria způsobilosti

Věk způsobilý ke studiu

18 let a starší (Dospělý, Starší dospělý)

Přijímá zdravé dobrovolníky

Ne

Pohlaví způsobilá ke studiu

Všechno

Popis

Inclusion Criteria:

  • The patient must have signed and dated an Institutional Review Board (IRB)-approved consent form that conforms to federal and institutional guidelines

  • Age >= 18 years

  • Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2

  • Diagnosis of metastatic adenocarcinoma of colon or rectum without previous chemotherapy or any other systemic therapy for metastatic colorectal cancer except for one cycle of FOLFOX or capecitabine and oxaliplatin (CAPOX), either with or without bevacizumab prior to enrollment. Upon enrollment, the preceding single cycle of FOLFOX or FOLFOX + bevacizumab, if the patient received one, will not count towards patients' assessments per protocol. Cycle 1 day 1 (C1D1) of atezolizumab or C1D1 of mFOLFOX6/bevacizumab + atezolizumab will correspond to the first day the patient received therapy on trial

  • Tumor determined to be mismatch-repair deficient (dMMR) by Clinical Laboratory Improvement Act (CLIA)-certified immunohistochemical (IHC) assay with a panel of all four IHC markers, including MLH1, MSH2, PMS2, and MSH6; alternatively, MSI-H diagnosed by polymerase chain reaction (PCR)-based assessment of microsatellite alterations (either Bethesda markers or Pentaplex panel) or by next-generation sequencing (NGS) are eligible

  • Documentation by PET/CT scan, CT scan, or MRI that the patient has measurable metastatic disease per RECIST 1.1

  • No immediate need for surgical intervention for the primary tumor or palliative diversion/bypass

  • Absolute neutrophil count (ANC) must be >= 1500/mm^3 (obtained within 28 days prior randomization)

  • Platelet count must be >= 100,000/mm^3 (obtained within 28 days prior randomization)

  • Hemoglobin must be >= 8 g/dL (obtained within 28 days prior randomization)

  • Total bilirubin must be =< 4 x ULN (upper limit of normal) (obtained within 28 days prior randomization); and

  • Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) must be =< 3 x ULN for the lab with the following exception: for patients with documented liver metastases, AST and ALT must be =< 5 x ULN (obtained within 28 days prior randomization)

  • Calculated creatinine clearance >= 30 mL/min (obtained within 28 days prior randomization)

  • A urine sample tested for proteinuria by either the dipstick method, urinalysis (UA), or a urine protein creatinine (UPC) ratio:

    • The dipstick method must indicate 0-1+ protein; if dipstick reading is >= 2+, a 24-hour urine must be done and it must demonstrate < 1.0 g of protein per 24 hours or a UPC ratio < 1.0
    • A urine protein creatinine (UPC) ratio must be < 1.0; if the UPC ratio is >= 1.0 a 24-hour urine must be done and it must demonstrate < 1.0 g of protein per 24 hours
    • Urinalysis must indicate < 30 mg/dl. If urinalysis >= 30 mg/dl, a 24-hour urine must be done and it must demonstrate < 1.0 g of protein per 24 hours or a UPC ratio < 1.0
  • International normalized ratio of prothrombin time (INR) and prothrombin time (PT) must be =< 1.5 x ULN for the lab within 28 days before randomization; patients who are therapeutically treated with an agent such as warfarin may participate if they are on a stable dose and no underlying abnormality in coagulation parameters exists per medical history, regardless of PT/INR results

  • Pregnancy test done within 28 days prior randomization must be negative (for women of childbearing potential only); pregnancy testing should be performed according to institutional standards; administration of atezolizumab or mFOLFOX6/bevacizumab/atezolizumab may have an adverse effect on pregnancy and poses a risk to the human fetus, including embryo-lethality; should a woman become pregnant or suspect she is pregnant while she or her partner is participating in this study, she should inform her treating physician immediately

  • Women of child-bearing potential and men must agree to use adequate contraception methods that result in a failure rate of < 1% per year during the treatment period (hormonal or barrier method of birth control; abstinence) prior to study entry, for the duration of study participation, and for 5 months (150 days) after the last dose of atezolizumab, 6 months after the last dose of bevacizumab, and 6 months after the last dose of mFOLFOX6; a woman is considered to be of childbearing potential if she is not postmenopausal, has not reached a postmenopausal state (>= 12 continuous months of amenorrhea with no identified cause other than menopause), and has not undergone surgical sterilization (removal of ovaries and/or uterus); examples of contraceptive methods with a failure rate of < 1% per year include: bilateral tubal ligation; male partner sterilization; intrauterine devices; the reliability of sexual abstinence should be evaluated in relation to the duration of the clinical study and the preferred and usual lifestyle of the patient; periodic abstinence (e.g., calendar, ovulation, symptothermal, or postovulation methods) and withdrawal are not acceptable methods of contraception; men must refrain from donating sperm during this same period

Exclusion Criteria:

  • Known hypersensitivity to Chinese hamster ovary cell products or other recombinant human antibodies, fluoropyrimidines, folic acid derivatives or oxaliplatin

  • Uncontrolled high blood pressure defined as systolic blood pressure (BP) > 150 mmHg or diastolic BP > 100 mmHg with or without anti-hypertensive medication; patients with initial BP elevations are eligible if initiation or adjustment of BP medication lowers pressure to meet entry criteria

  • Documented New York Heart Association (NYHA) class III or IV congestive heart failure

  • Serious or non-healing wound, skin ulcer, or bone fracture

  • History of inherited bleeding diathesis, gastrointestinal (GI) perforation, significant vascular disease (e.g., aortic aneurysm requiring surgical repair or recent arterial thrombosis or symptomatic peripheral ischemia, transient ischemic attack [TIA], cerebrovascular accident [CVA] or arterial thrombotic event), abdominal fistula, intra-abdominal abscess, or active GI bleeding (with cause not addressed) within 6 months prior to randomization, or other medical condition in the opinion of the treating oncologist that makes the risk of cardiovascular or bleeding complications with bevacizumab use unacceptably high

  • Other malignancies are excluded unless the patient has completed therapy for the malignancy >= 12 months prior to randomization and is considered disease-free; patients with the following cancers are eligible if diagnosed and treated within the past 12 months: in situ carcinomas or basal cell and squamous cell carcinoma of the skin

  • Known DPD (dihydro pyrimidine dehydrogenase) deficiency

  • Symptomatic peripheral sensory neuropathy >= grade 2 (Common Terminology Criteria for Adverse Events [CTCAE] version [v] 5.0)

  • Prior treatment with oxaliplatin chemotherapy within 6 months prior to randomization

  • History of grade 2 hemoptysis (defined as 2.5 mL of bright red blood per episode) within 1 month prior to screening

  • Prior treatment with anti-PD-1, or anti-PD-L1 therapeutic antibody or pathway-targeting agents; patients who have received prior treatment with anti-CTLA-4 may be enrolled provided the following requirements are met:

    • Minimum of 12 weeks from the first dose of anti-CTLA-4 and > 6 weeks from the last dose to randomization
    • No history of severe immune-related adverse effects (CTCAE grade 3 and 4) from anti-CTLA-4
  • Treatment with systemic immunosuppressive medications (including, but not limited to, prednisone, cyclophosphamide, azathioprine, methotrexate, thalidomide, and anti-tumor necrosis factor [anti-TNF] agents) within 14 days prior to randomization; however,

    • Patients who have received acute, low dose, systemic immunosuppressant medications (e.g., a one-time dose of dexamethasone for nausea; or chronic daily treatment with corticosteroids with a dose of =< 10 mg/day methylprednisolone equivalent) may be enrolled
    • The use of inhaled corticosteroids and mineralocorticoids (e.g., fludrocortisone) for patients with orthostatic hypotension or adrenocortical insufficiency is allowed
  • Known clinically significant liver disease, including active viral, alcoholic, or other hepatitis; cirrhosis; fatty liver; and inherited liver disease; however,

    • Patients with past or resolved hepatitis B infection (defined as having a negative hepatitis B surface antigen [HbsAg] test and a positive anti-HBc [antibody to hepatitis B core antigen] antibody test) are eligible if polymerase chain reaction (PCR) for hepatits B virus (HBV) ribonucleic acid (RNA) is negative per local guidelines
    • Patients positive for hepatitis C virus (HCV) antibody are eligible only if polymerase chain reaction (PCR) is negative for HCV RNA per local guidelines
  • History or risk of autoimmune disease, including, but not limited to, systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease, vascular thrombosis associated with antiphospholipid syndrome, Wegener's granulomatosis, Sjogren's syndrome, Bell's palsy, Guillain-Barre syndrome, multiple sclerosis, autoimmune thyroid disease, vasculitis, or glomerulonephritis; however,

    • Patients with a history of autoimmune hypothyroidism on a stable dose of thyroid replacement hormone may be eligible

    • Patients with controlled type 1 diabetes mellitus on a stable insulin regimen may be eligible

    • Patients with eczema, psoriasis, lichen simplex chronicus or vitiligo with dermatologic manifestations only (e.g., patients with psoriatic arthritis would be excluded) are permitted provided that they meet the following conditions:

      • Patients with psoriasis must have a baseline ophthalmologic exam to rule out ocular manifestations
      • Rash must cover less than 10% of body surface area (BSA)
      • Disease is well controlled at baseline and only requiring low potency topical steroids (e.g., hydrocortisone 2.5%, hydrocortisone butyrate 0.1%, fluocinolone 0.01%, desonide 0.05%, alclometasone dipropionate 0.05%)
      • No acute exacerbations of underlying condition within the last 12 months (not requiring psoralen plus ultraviolet A radiation [PUVA], methotrexate, retinoids, biologic agents, oral calcineurin inhibitors; high potency or oral steroids)
  • History of idiopathic pulmonary fibrosis, organizing pneumonia (i.e., bronchiolitis obliterans, cryptogenic organizing pneumonia, etc.), or active or recently active (within 90 days of randomization) pneumonitis (including drug induced) that required systemic immunosuppressive therapy (i.e. corticosteroids, etc.). History of radiation pneumonitis in the radiation field (fibrosis) is permitted

  • History of severe allergic, anaphylactic, or other hypersensitivity reactions to chimeric or humanized antibodies or fusion proteins

  • Patients with known active tuberculosis (TB) are excluded

  • Severe infections within 28 days prior to randomization, including but not limited to, hospitalization for complications of infection, bacteremia, or severe pneumonia

  • Signs or symptoms of infection within 14 days prior to randomization

  • Received oral or intravenous (IV) antibiotics within 14 days prior to randomization; patients receiving prophylactic antibiotics (e.g., for prevention of a urinary tract infection or chronic obstructive pulmonary disease) are eligible

  • Major surgical procedure, open biopsy, or significant traumatic injury within 28 days prior to randomization or anticipation of need for a major surgical procedure during the course of the study

  • The administration of a live, attenuated vaccine within 28 days prior to randomization

  • Pregnant women are excluded from this study because atezolizumab is an agent with the potential for teratogenic or abortifacient effects; because there is an unknown but potential risk for adverse events in nursing infants secondary to treatment of the mother with atezolizumab, breastfeeding should be discontinued if the mother is treated with atezolizumab; these potential risks may also apply to other agents used in this study; (Note: pregnancy testing should be performed within 28 days prior to randomization according to institutional standards for women of childbearing potential)

  • Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months are eligible for this trial

  • Patients with prior allogeneic bone marrow transplantation or prior solid organ transplantation

Studijní plán

Tato část poskytuje podrobnosti o studijním plánu, včetně toho, jak je studie navržena a co studie měří.

Jak je studie koncipována?

Detaily designu

  • Primární účel: Léčba
  • Přidělení: Randomizované
  • Intervenční model: Paralelní přiřazení
  • Maskování: Žádné (otevřený štítek)

Zbraně a zásahy

Skupina účastníků / Arm
Intervence / Léčba
Aktivní komparátor: Arm I (bevacizumab, mFOLFOX6)

Patients receive bevacizumab intravenously (IV) over 30-90 minutes on day 1, oxaliplatin IV over 2 hours on day 1 of cycles 1-10, leucovorin calcium IV over 2 hours on day 1, and fluorouracil IV over 46-48 hours on days 1 and 2. Treatment with oxaliplatin repeats every 2 weeks for up to 10 cycles in the absence of disease progression or unacceptable toxicity. Treatment of bevacizumab, leucovorin calcium, and fluorouracil repeat every 2 weeks for up to 48 cycles in the absence of disease progression or unacceptable toxicity. Patients undergo CT with or without PET or MRI throughout the trial. Patients may also undergo collection of optional blood samples throughout the trial. (CLOSED TO ACCRUAL)

Ancillary studies

Ostatní jména:
  • Hodnocení kvality života

Given IV

Ostatní jména:
  • Avastin
  • ABP 215
  • Anti-VEGF
  • Anti-VEGF humanizovaná monoklonální protilátka
  • Monoklonální protilátka proti VEGF SIBP04
  • Anti-VEGF rhuMAb
  • Bevacizumab awwb
  • Bevacizumab Biosimilar ABP 215
  • Bevacizumab Biosimilar BEVZ92
  • Bevacizumab Biosimilar BI 695502
  • Bevacizumab Biosimilar CBT 124
  • Bevacizumab Biosimilar CT-P16
  • Bevacizumab Biosimilar FKB238
  • Bevacizumab Biosimilar GB-222
  • Bevacizumab Biosimilar HD204
  • Bevacizumab Biosimilar HLX04
  • Bevacizumab Biosimilar IBI305
  • Bevacizumab Biosimilar LY01008
  • Bevacizumab Biosimilar MIL60
  • Bevacizumab Biosimilar Mvasi
  • Bevacizumab Biosimilar MYL-1402O
  • Bevacizumab Biosimilar QL 1101
  • Bevacizumab Biosimilar RPH-001
  • Bevacizumab Biosimilar SCT501
  • Bevacizumab Biosimilar Zirabev
  • Bevacizumab-awwb
  • Bevacizumab-bvzr
  • BP102
  • BP102 Biosimilar
  • HD204
  • Imunoglobulin G1 (lidský-myší monoklonální rhuMab-VEGF gama-řetězcový anti-lidský vaskulární endoteliální růstový faktor), disulfid s lidským-myším monoklonálním lehkým řetězcem rhuMab-VEGF, dimer
  • Mvasi
  • MYL-1402O
  • Rekombinantní humanizovaná anti-VEGF monoklonální protilátka
  • rhuMab-VEGF
  • SCT501
  • SIBP 04
  • SIBP-04
  • SIBP04
  • Zirabev
  • Avegra
  • QL1101
  • IBI305
  • Byvasda
  • Bevacizumab Biosimilar QL1101
  • BAT1706
  • BAT 1706
  • BAT-1706
  • BAT1706 Biosimilar
  • Bevacizumab Biosimilar BAT1706
  • Bevacizumab-adcd
  • CT-P16
  • Vegzelma
  • Alymsys
  • ABP-215
  • ABP215
  • Aybintio
  • Bevacizumab-aybi
  • Bevacizumab-ekvi
  • Bevacizumab-maly
  • Bevacizumab-onbe
  • ČT P16
  • CTP16
  • Ekvidacentní
  • Onbevzi
  • Avzivi
  • Bevacizumab Biosimilar MB02
  • Bevacizumab-tnjn
  • FKB 238
  • FKB-238
  • FKB238
  • MB 02
  • MB-02
  • MB02
  • Oyavas
  • PF 06439535
  • PF-06439535
  • PF06439535
  • Bevacizumab-aveg
  • Bevacizumab-byva
  • Bevacizumab-nwgd
  • Jobevne
  • IBI 305
  • IBI-305

Given IV

Ostatní jména:
  • 5-Fluracil
  • Fluracil
  • 5 fluorouracil
  • 5 Fluorouracilum
  • 5 FU
  • 5-Fluor-2,4(lH,3H)-pyrimidindion
  • 5-Fluoruracil
  • 5-Fu
  • 5FU
  • AccuSite
  • Carac
  • Fluoro uracil
  • Fluuracil
  • Flurablastin
  • Fluracedyl
  • Fluril
  • Fluroblastin
  • Ribofluor
  • Ro 2-9757
  • Ro-2-9757

Undergo MRI

Ostatní jména:
  • MRI
  • Magnetická rezonance
  • Skenování magnetickou rezonancí
  • Lékařské zobrazování, magnetická rezonance / nukleární magnetická rezonance
  • PAN
  • MR zobrazování
  • MRI skenování
  • NMR zobrazování
  • NMRI
  • Nukleární magnetická rezonance
  • Zobrazování magnetickou rezonancí (MRI)
  • sMRI
  • Magnetická rezonance (postup)
  • Strukturální MRI

Ancillary studies

Undergo collection of blood samples

Ostatní jména:
  • Sběr biologických vzorků
  • Odebrán biovzorek
  • Sbírka vzorků

Given IV

Ostatní jména:
  • 1-OHP
  • Dacotin
  • Dacplat
  • Eloxatin
  • Ai Heng
  • Aiheng
  • Diaminocyklohexan Oxalatoplatina
  • JM-83
  • Oxalatoplatina
  • RP 54780
  • RP-54780
  • SR-96669
  • SR96669
  • Elplat
  • JM 83
  • JM83
  • RP54780
  • SR 96669

Undergo CT or CT/PET

Ostatní jména:
  • ČT
  • KOČKA
  • CAT skenování
  • Počítačová axiální tomografie
  • Počítačová tomografie
  • CT vyšetření
  • tomografie
  • Počítačová axiální tomografie (postup)
  • Počítačová tomografie (CT).
  • Diagnostické skenování CAT
  • Typ služby diagnostického skenování CAT

Given IV

Ostatní jména:
  • Kyselina folinová

Undergo CT/PET

Ostatní jména:
  • Lékařské zobrazování, pozitronová emisní tomografie
  • PET
  • PET skenování
  • Skenování pozitronové emisní tomografie
  • Pozitronová emisní tomografie
  • PT
  • Pozitronová emisní tomografie (postup)
Experimentální: Arm II (atezolizumab)

Patients receive atezolizumab IV over 30-60 minutes on day 1. Treatment repeats every 2 weeks for up to 48 cycles in the absence of disease progression or unacceptable toxicity. Patients undergo CT with or without PET or MRI throughout the trial. Patients may also undergo collection of optional blood samples throughout the trial.

Ancillary studies

Ostatní jména:
  • Hodnocení kvality života

Undergo MRI

Ostatní jména:
  • MRI
  • Magnetická rezonance
  • Skenování magnetickou rezonancí
  • Lékařské zobrazování, magnetická rezonance / nukleární magnetická rezonance
  • PAN
  • MR zobrazování
  • MRI skenování
  • NMR zobrazování
  • NMRI
  • Nukleární magnetická rezonance
  • Zobrazování magnetickou rezonancí (MRI)
  • sMRI
  • Magnetická rezonance (postup)
  • Strukturální MRI

Ancillary studies

Undergo collection of blood samples

Ostatní jména:
  • Sběr biologických vzorků
  • Odebrán biovzorek
  • Sbírka vzorků

Given IV

Ostatní jména:
  • Tecentriq
  • MPDL3280A
  • RO5541267
  • RG7446
  • MPDL 3280A
  • MPDL 328OA
  • MPDL-3280A
  • MPDL328OA
  • RG-7446
  • RG 7446
  • RO 5541267
  • RO-5541267

Undergo CT or CT/PET

Ostatní jména:
  • ČT
  • KOČKA
  • CAT skenování
  • Počítačová axiální tomografie
  • Počítačová tomografie
  • CT vyšetření
  • tomografie
  • Počítačová axiální tomografie (postup)
  • Počítačová tomografie (CT).
  • Diagnostické skenování CAT
  • Typ služby diagnostického skenování CAT

Undergo CT/PET

Ostatní jména:
  • Lékařské zobrazování, pozitronová emisní tomografie
  • PET
  • PET skenování
  • Skenování pozitronové emisní tomografie
  • Pozitronová emisní tomografie
  • PT
  • Pozitronová emisní tomografie (postup)
Experimentální: Arm III (atezolizumab, bevacizumab, mFOLFOX6)

Patients receive atezolizumab IV over 30-60 minutes on day 1. Treatment repeats every 2 weeks for up to 48 cycles in the absence of disease progression or unacceptable toxicity. Patients also receive bevacizumab IV over 30-90 minutes on day 1, oxaliplatin IV over 2 hours on day 1 cycles 1-10, leucovorin calcium IV over 2 hours on day 1, and fluorouracil IV over 46-48 hours on day 1. Treatment with oxaliplatin repeats every 2 weeks for up to 10 cycles in the absence of disease progression or unacceptable toxicity. Treatment of bevacizumab, leucovorin calcium, and fluorouracil repeat every 2 weeks for up to 48 cycles in the absence of disease progression or unacceptable toxicity. Patients undergo CT with or without PET or MRI throughout the trial. Patients may also undergo collection of optional blood samples throughout the trial.

Ancillary studies

Ostatní jména:
  • Hodnocení kvality života

Given IV

Ostatní jména:
  • Avastin
  • ABP 215
  • Anti-VEGF
  • Anti-VEGF humanizovaná monoklonální protilátka
  • Monoklonální protilátka proti VEGF SIBP04
  • Anti-VEGF rhuMAb
  • Bevacizumab awwb
  • Bevacizumab Biosimilar ABP 215
  • Bevacizumab Biosimilar BEVZ92
  • Bevacizumab Biosimilar BI 695502
  • Bevacizumab Biosimilar CBT 124
  • Bevacizumab Biosimilar CT-P16
  • Bevacizumab Biosimilar FKB238
  • Bevacizumab Biosimilar GB-222
  • Bevacizumab Biosimilar HD204
  • Bevacizumab Biosimilar HLX04
  • Bevacizumab Biosimilar IBI305
  • Bevacizumab Biosimilar LY01008
  • Bevacizumab Biosimilar MIL60
  • Bevacizumab Biosimilar Mvasi
  • Bevacizumab Biosimilar MYL-1402O
  • Bevacizumab Biosimilar QL 1101
  • Bevacizumab Biosimilar RPH-001
  • Bevacizumab Biosimilar SCT501
  • Bevacizumab Biosimilar Zirabev
  • Bevacizumab-awwb
  • Bevacizumab-bvzr
  • BP102
  • BP102 Biosimilar
  • HD204
  • Imunoglobulin G1 (lidský-myší monoklonální rhuMab-VEGF gama-řetězcový anti-lidský vaskulární endoteliální růstový faktor), disulfid s lidským-myším monoklonálním lehkým řetězcem rhuMab-VEGF, dimer
  • Mvasi
  • MYL-1402O
  • Rekombinantní humanizovaná anti-VEGF monoklonální protilátka
  • rhuMab-VEGF
  • SCT501
  • SIBP 04
  • SIBP-04
  • SIBP04
  • Zirabev
  • Avegra
  • QL1101
  • IBI305
  • Byvasda
  • Bevacizumab Biosimilar QL1101
  • BAT1706
  • BAT 1706
  • BAT-1706
  • BAT1706 Biosimilar
  • Bevacizumab Biosimilar BAT1706
  • Bevacizumab-adcd
  • CT-P16
  • Vegzelma
  • Alymsys
  • ABP-215
  • ABP215
  • Aybintio
  • Bevacizumab-aybi
  • Bevacizumab-ekvi
  • Bevacizumab-maly
  • Bevacizumab-onbe
  • ČT P16
  • CTP16
  • Ekvidacentní
  • Onbevzi
  • Avzivi
  • Bevacizumab Biosimilar MB02
  • Bevacizumab-tnjn
  • FKB 238
  • FKB-238
  • FKB238
  • MB 02
  • MB-02
  • MB02
  • Oyavas
  • PF 06439535
  • PF-06439535
  • PF06439535
  • Bevacizumab-aveg
  • Bevacizumab-byva
  • Bevacizumab-nwgd
  • Jobevne
  • IBI 305
  • IBI-305

Given IV

Ostatní jména:
  • 5-Fluracil
  • Fluracil
  • 5 fluorouracil
  • 5 Fluorouracilum
  • 5 FU
  • 5-Fluor-2,4(lH,3H)-pyrimidindion
  • 5-Fluoruracil
  • 5-Fu
  • 5FU
  • AccuSite
  • Carac
  • Fluoro uracil
  • Fluuracil
  • Flurablastin
  • Fluracedyl
  • Fluril
  • Fluroblastin
  • Ribofluor
  • Ro 2-9757
  • Ro-2-9757

Undergo MRI

Ostatní jména:
  • MRI
  • Magnetická rezonance
  • Skenování magnetickou rezonancí
  • Lékařské zobrazování, magnetická rezonance / nukleární magnetická rezonance
  • PAN
  • MR zobrazování
  • MRI skenování
  • NMR zobrazování
  • NMRI
  • Nukleární magnetická rezonance
  • Zobrazování magnetickou rezonancí (MRI)
  • sMRI
  • Magnetická rezonance (postup)
  • Strukturální MRI

Ancillary studies

Undergo collection of blood samples

Ostatní jména:
  • Sběr biologických vzorků
  • Odebrán biovzorek
  • Sbírka vzorků

Given IV

Ostatní jména:
  • Tecentriq
  • MPDL3280A
  • RO5541267
  • RG7446
  • MPDL 3280A
  • MPDL 328OA
  • MPDL-3280A
  • MPDL328OA
  • RG-7446
  • RG 7446
  • RO 5541267
  • RO-5541267

Given IV

Ostatní jména:
  • 1-OHP
  • Dacotin
  • Dacplat
  • Eloxatin
  • Ai Heng
  • Aiheng
  • Diaminocyklohexan Oxalatoplatina
  • JM-83
  • Oxalatoplatina
  • RP 54780
  • RP-54780
  • SR-96669
  • SR96669
  • Elplat
  • JM 83
  • JM83
  • RP54780
  • SR 96669

Undergo CT or CT/PET

Ostatní jména:
  • ČT
  • KOČKA
  • CAT skenování
  • Počítačová axiální tomografie
  • Počítačová tomografie
  • CT vyšetření
  • tomografie
  • Počítačová axiální tomografie (postup)
  • Počítačová tomografie (CT).
  • Diagnostické skenování CAT
  • Typ služby diagnostického skenování CAT

Given IV

Ostatní jména:
  • Kyselina folinová

Undergo CT/PET

Ostatní jména:
  • Lékařské zobrazování, pozitronová emisní tomografie
  • PET
  • PET skenování
  • Skenování pozitronové emisní tomografie
  • Pozitronová emisní tomografie
  • PT
  • Pozitronová emisní tomografie (postup)

Co je měření studie?

Primární výstupní opatření

Měření výsledku
Popis opatření
Časové okno
Progression free survival (PFS)
Časové okno: From the time from randomization until first confirmed progression or death from any cause, assessed up to 5 years

The analysis set is intent-to-treat (ITT). The experimental arms will be compared to the control arm by the log-rank test stratified by BRAF status (V600E mutation or not), metastatic disease: (liver-only, extra-hepatic), and prior adjuvant therapy for colon cancer (yes, no). Hazard ratios and associated confidence intervals from a stratified Cox regression model will also be reported along with estimates of the distributions of time to PFS event by the method of Kaplan and Meier. Sensitivity analyses accounting for 2 or more consecutively missed scheduled tumor imaging scans before progression/death will also be conducted.

From the time from randomization until first confirmed progression or death from any cause, assessed up to 5 years

Sekundární výstupní opatření

Měření výsledku
Popis opatření
Časové okno
Míra PFS
Časové okno: Ve 12 měsících
Ve 12 měsících
Overall survival (OS)
Časové okno: The time from randomization to death from any cause, assessed up to 5 years

Will be analyzed using the stratified log rank test and the ITT population. Kaplan-Meier plots will illustrate the distribution of these endpoints by treatment. Stratified Cox regression models will be used to estimate hazard ratios and associated confidence intervals.

The time from randomization to death from any cause, assessed up to 5 years
Objective response rate (ORR) (complete response [CR] or partial response [PR])
Časové okno: Up to 5 years

Assessed by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1. Will be analyzed by a logistic regression models that control for the stratification factors (BRAF status, liver involvement, and adjuvant chemotherapy [chemo]) using the ITT population. Observed proportions along with confidence intervals will be presented by treatment.

Up to 5 years
Incidence of adverse events
Časové okno: Up to 30 days after last cycle

Defined by Common Terminology Criteria for Adverse Events (CTCAE) version 5.0. The safety profile will be described by tabulating the maximum observed grade of adverse event for each individual adverse event, for each system organ class, and overall using the Safety population.

Up to 30 days after last cycle
Disease control rate (CR + PR + stable disease [SD])
Časové okno: At 12 months

Assessed by RECIST 1.1. Will be analyzed by a logistic regression models that control for the stratification factors (BRAF status, liver involvement, and adjuvant chemo) using the ITT population. Observed proportions along with confidence intervals will be presented by treatment.

At 12 months
Duration of overall response (CR or PR)
Časové okno: From the time of first response to first confirmed progression by the study investigator or death from any cause, assessed up to 5 years

Assessed by RECIST 1.1. Will be analyzed using the stratified log rank test and the ITT population. Kaplan-Meier plots will illustrate the distribution of these endpoints by treatment. Stratified Cox regression models will be used to estimate hazard ratios and associated confidence intervals.

From the time of first response to first confirmed progression by the study investigator or death from any cause, assessed up to 5 years
Duration of SD
Časové okno: From the time of first on-study assessment of SD to first progression by the study investigator or death from any cause, assessed up to 5 years

Assessed per RECIST 1.1. Will be analyzed using the stratified log rank test and the ITT population. Kaplan-Meier plots will illustrate the distribution of these endpoints by treatment. Stratified Cox regression models will be used to estimate hazard ratios and associated confidence intervals.

From the time of first on-study assessment of SD to first progression by the study investigator or death from any cause, assessed up to 5 years

Další výstupní opatření

Měření výsledku
Popis opatření
Časové okno
Severity of fatigue
Časové okno: At 16 weeks

Will use the ITT population. Measured by the Patient Reported Outcomes Measurement Information System (PROMIS) Fatigue questionnaire. Will be compared between the control arm (Chemo-bevacizumab [Bev]) and the experimental arm by means of ordinal logistic regression with adjustment for the corresponding baseline measurement and stratification variables. The comparison will be performed at the significance level of 0.05 (two-sided) and the clinical meaningfulness of the comparison will be considered.

At 16 weeks
Physical functioning
Časové okno: At 16 weeks

Will use the ITT population. Measured by the European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire (QLQ)-C30 physical functioning scale. Will be compared between the control arm (Chemo-Bev) and the experimental arm by means of ordinal logistic regression with adjustment for the corresponding baseline measurement and stratification variables. The comparison will be performed at the significance level of 0.05 (two-sided) and the clinical meaningfulness of the comparison will be considered.

At 16 weeks
Health utility scores
Časové okno: Up to 5 years

Will use the ITT population. Will be measured using the EuroQoL 5 Dimensions 5 Levels (EQ-5D-5L) questionnaire.

Up to 5 years
Proportion of patients reporting each response option at each assessment timepoint by treatment arm for item GP5 from the Functional Assessment of Cancer Therapy - General (FACT-G)
Časové okno: Up to 5 years

Will use the ITT population.

Up to 5 years
Intratumoral lymphocyte PD-L1+ expression (>= 1 % is positive) by immunohistochemistry (IHC) as a predictive biomarker of efficacy
Časové okno: Up to 5 years

Will use the ITT population.

Up to 5 years
Efficacy dependent on the number of somatic mutations
Časové okno: Up to 5 years

Will use the ITT population.

Up to 5 years
Efficacy in tumors with MLH1 silencing
Časové okno: Up to 5 years

Will use the ITT population.

Up to 5 years
Change in quantification of cell free deoxyribonucleic acid (cfDNA) mutations
Časové okno: Baseline up to 5 years

Will use the ITT population.

Baseline up to 5 years
Development of progression or relapse to treatment in cfDNA
Časové okno: Up to 5 years

Will use the ITT population.

Up to 5 years
Changes in T-cell repertoire diversity as a predictive biomarker of efficacy
Časové okno: Baseline up to 5 years

Will use the ITT population.

Baseline up to 5 years
PFS of patients with high levels of diversity
Časové okno: Up to 5 years

Compared to patients with low levels of diversity. Will use the ITT population.

Up to 5 years
Change in T-cell diversity
Časové okno: Baseline to first restaging between immunotherapy arms and the standard of care arm

Will use the ITT population.

Baseline to first restaging between immunotherapy arms and the standard of care arm
Mechanism of immune resistance to PD-1 blockade in mismatch repair deficient (dMMR)/microsatellite instability-high metastatic colorectal cancer (mCRC) by comparative analysis of tumor samples collected
Časové okno: Baseline up to 5 years

Will use the ITT population.

Baseline up to 5 years

Spolupracovníci a vyšetřovatelé

Zde najdete lidi a organizace zapojené do této studie.

Sponzor

Vyšetřovatelé

  • Vrchní vyšetřovatel: Caio Max S Rocha Lima, NRG Oncology

Publikace a užitečné odkazy

Osoba odpovědná za zadávání informací o studiu tyto publikace poskytuje dobrovolně. Mohou se týkat čehokoli, co souvisí se studiem.

Termíny studijních záznamů

Tato data sledují průběh záznamů studie a předkládání souhrnných výsledků na ClinicalTrials.gov. Záznamy ze studií a hlášené výsledky jsou před zveřejněním na veřejné webové stránce přezkoumány Národní lékařskou knihovnou (NLM), aby se ujistily, že splňují specifické standardy kontroly kvality.

Hlavní termíny studia

Začátek studia (Aktuální)

19. ledna 2018

Primární dokončení (Odhadovaný)

1. června 2027

Dokončení studie (Odhadovaný)

1. června 2027

Termíny zápisu do studia

První předloženo

19. prosince 2016

První předloženo, které splnilo kritéria kontroly kvality

19. prosince 2016

První zveřejněno (Odhadovaný)

20. prosince 2016

Aktualizace studijních záznamů

Poslední zveřejněná aktualizace (Aktuální)

12. listopadu 2026

Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality

11. listopadu 2026

Naposledy ověřeno

1. září 2026

Více informací

Termíny související s touto studií

Další identifikační čísla studie

  • NCI-2016-01961
  • U10CA180868 (Grant/smlouva NIH USA)
  • NCI-2016-01961 (Identifikátor registru: CTRP (Clinical Trial Reporting Program))
  • NRG-GI004/S1610
  • NRG-GI004 (Jiný identifikátor: CTEP)
  • NRG-GI004 (Jiný identifikátor: NRG Oncology)

Informace o lécích a zařízeních, studijní dokumenty

Studuje lékový produkt regulovaný americkým FDA

Ano

Studuje produkt zařízení regulovaný americkým úřadem FDA

Ne

Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .